Pediatric medulloblastoma: Prognostic value of p53, bcl-2, Mib-1, and microvessel density

Journal of Neuro-Oncology

Volumn 45, Issue 2, 1999, Pages 103-110

  Miralbell, Raymond ^b   Tolnay, Markus ^c   Bieri, Sabine ^c   Probst, Alphonse ^c   Sappino, André Pascal ^c   Berchtold, Willi ^a   Pepper, Michael S ^c   Pizzolato, Gianpaolo ^c  

^a ETH ZURICH   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c NONE

Author keywords

bcl 2; Factor VIII related antigen; Immunohistochemistry; Medulloblastoma; Mib 1; Microvessel counts; p53

Indexed keywords

PROTEIN BCL 2; PROTEIN P53; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ARTICLE; CANCER TISSUE; CELL PROLIFERATION; CHILD; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MEDULLOBLASTOMA; MICROVASCULATURE; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SUBARACHNOID SPACE; TUMOR VASCULARIZATION;

EID: 0033498264     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006330324991     Document Type: Article

References (37)

1. Yasue M, Tomita T, Engelhard H, Gonzalez-Crussi F, McLone DG, Bauer KD: Prognostic importance of DNA ploidy in medulloblastoma of childhood. J Neurosurg 70: 385-391, 1989
2. Tait DM, Eeles RA, Carter R, Ashley S, Ormerod MG: Ploidy and proliferative index in medulloblastoma: useful prognostic factors? Eur J Cancer 29A: 1383-1387, 1993
3. Gajjar AJ, Heideman RL, Douglass EC, Kun LE, Kovnar EH, Sanford RA, Fairclough DL, Ayers D, Look AT: Relation of tumor-cell ploidy to survival in children with medulloblastoma. J Clin Oncol 11: 2211-2217, 1993
4. Ito S, Hoshino T, Prados MD, Edwards MSB: Cell kinetics of medulloblastomas. Cancer 70: 671-678, 1992
5. Karamitopoulou E, Perentes E, Diamantis I, Maraziotis T: Ki-67 immunoreactivity in human central nervous system tumors : a study with MIB 1 monoclonal antibody on archival material. Acta Neuropathol 87: 47-54, 1994
6. Schiffer D, Cavalla P, Migheli A, Giordana MT, Chiado-Piat L: Tumor cell proliferation and apoptosis in medulloblastoma. Acta Neuropathol 87: 362-370, 1994
7. Bigner SH, Friedman HS, Vogelstein B, Oakes WJ, Bigner DD: Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts. Cancer Res 50: 2347-2350, 1990
8. MacGregor DN, Ziff EB: Elevated c-myc expression in childhood medulloblastomas. Pediatr Res 28: 63-68, 1990
9. McDonald JD, Daneshvar L, Willert JR, Matsumura K, Waldman F, Cogen PH: Physical mapping of chromosome 17p13.3 in the region of a putative tumor suppressor gene important in medulloblastoma. Genomics 23: 229-232, 1994
10. Batra SK, McLendon RE, Koo JS, Castellino-Prabhu S, Fuchs HE, Krisher JP, Friedman HS, Bigner DD, Bigner SH: Prognostic implications of chromosome 17p deletions in human medulloblastomas. J Neuro-Oncol 24: 39-45, 1995
11. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991
12. Germano IM, Ito M Cho KG, Hoshino T, Davis RL, Wilson CB: Correlation of histopathological features and proliferative potential of gliomas. J Neurosurg 70: 701-706, 1989
13. Li VW, Folkerth RD, Watanabe H, Yu C, Rupnick M, Barnes P, Scott RM, Black PM, Sallan SE, Folkman J: Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet 344: 82-86, 1994
14. Leon SP, Folkerth RD, Black PM: Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 77: 362-372, 1996
15. Chang CH, Housepian EM, Herbert Jr CJ: An operative staging and a megavoltage radiotherapy technique for cerebellar medulloblastoma. Radiology 93: 1351-1359, 1969
16. Newcomb EW, Bhalla SK, Parrish CL, Hayes RL, Cohen H, Miller DC: bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status. Acta Neuropathol 94: 369-375, 1997
17. Ohkoudo M, Sawa H, Hara M, Saruta K, Aiso T, Ohki R, Yamamoto H, Maemura E, Shiina Y, Fujii M, Saitu: Expression of p53, MDM2 protein, and Ki-67 antigen in recurrent meningiomas. J Neuro-Oncol 38: 41-49, 1998
18. Jaros E, Lunec J, Perry RH, Kelly PJ, Pearson ADJ: p53 protein overexpression identifies a group of central primitive neuroectodermal tumors with poor prognosis. Br J Cancer 68: 801-807, 1993
19. Saylors RL III, Sidransky D, Friedman HS, Bigner SH, Bigner DD, Vogelstein B, Brodeur GM: Infrequent p53 gene mutations in medulloblastomas. Cancer Res 51: 4721-4723, 1991
20. Hui-Kuo SG, Burman F, Dee S, Israel MA: Differential induction of p53-mediated apoptosis in medulloblastomas and gliomas correlates with their ability to induce bax. Int J Radiat Oncol Biol Phys 39(suppl): 178, 1997
21. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ: bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348: 334-336, 1990
22. Korsmeyer SJ: bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80: 879-886, 1992
23. Krajewski S, Krajewska M, Ehrmann J, Sikorska M, Lach B, Chatten J, Reed JCI: Immunohistochemical analysis of bcl-2, bcl-x, mcl-1, and bax in tumors of central and peripheral nervous system origin. Am J Pathol 150: 805-814, 1997
24. Heck K, Pyle P, Bruner JH: bcl-2 expression in cerebellar medulloblastomas. Brain Pathol 4: 438, 1994
25. Nakasu S, Nakasu Y, Nioka H, Nakajima M, Handa H: bcl-2 protein expression in tumors of the central nervous system. Acta Neuropathol 88: 520-526, 1994
26. Schiffer D, Cavalla P, Migheli A, Giordana MT, Chiado-Piat L: bcl-2 distribution in neuroepithelial tumors: an immunohistochemical study. J Neuro-Oncol 27: 101-109, 1996
27. Ballantyne ES, McDowell H, May PL, Gosden C: Childhood medulloblastoma: bcl-2 expression and survival. J Neuro-Oncol 30: 99, 1996
28. Oka H, Satoh Y, Kawano N, Yagishita S, Kameya T: Expression of bcl-2 gene product in embryonal tumors of the central nervous system. Surg Neurol 45: 230-235, 1996
29. Alderson LM, Castleberg RL, Harsh GR, Louis DN, Henson JW: Human gliomas with wild-type p53 express bcl-2. Cancer Res 55: 999-1001, 1995
30. Ellison DW, Steart PV, Gatter KC, Weller RO: Apoptosis in cerebral astrocytic tumours and its relationship to expression of the bcl-2 and p53 proteins. Neuropathol Appl Neurobiol 21: 352-361, 1995
31. Jay V, Parkinson D, Becker L, Chan FW: Cell kinetic analysis in pediatric brain and spinal tumors: a study of 117 cases with Ki-67 quantification and flow cytometry. Pediatr Pathol 14: 253-276, 1994
32. Weidner N: Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J Pathol 184: 119-122, 1998
33. Wesseling P, Ruiter DJ, Burger PC: Angiogenesis in brain tumors; pathobiological and clinical aspects. J Neuro-Oncol 32: 253-265, 1997
34. Pietsch T, Valter MM, Wolf HK, Von Deimling A, Su Huang HJ, Cavenee WK, Wiestler OD: Expression and distribution of vascular endothelial growth factor protein in human brain tumors. Acta Neuropathol 93: 109-117, 1997
35. Taomoto K, Tomita T, Raimondi AJ, Leestma JE: Medulloblastomas in childhood: histological factors influencing patient's outcome. Child Nerv Syst 3: 354-360, 1987
36. Vermeulen PB, Gasparini SB, Fox SB, Toi M, Martin L, McCulloch P, Pezzella F, Viale G, Weidner N, Harris AL, Dirix LY: Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 32A: 2474-2484, 1996
37. Barbareschi M, Weidner N, Gasparini G: Microvessel density quantification in breast carcinomas. Assessment by light microscopy vs. a computer-aided analysis system. Appl Immunohistochem 3: 75-84, 1995